Search

Displaying results 6401 - 6410 of 9670 in total
  1. Drug

    OTOF-GT

    go.drugbank.com/drugs/DB18129
    Investigational

    OTOF-GT is a dual vector AAV gene therapy being investigated for the restoration of hearing loss associated with otoferlin deficiency.

  2. Drug

    TTX-MC138

    go.drugbank.com/drugs/DB18628
    Investigational

    [L48335] It is under investigation for the treatment of various metastatic cancers.

  3. Drug

    Senicapoc

    go.drugbank.com/drugs/DB06280
    Investigational

    [A259068] It is being investigated for the treatment of sickle cell disease.

  4. Drug

    Rifalazil

    go.drugbank.com/drugs/DB04934
    Investigational

    It is being investigated by ActivBiotics for the treatment of various bacterial infections.

  5. Drug

    Gantacurium

    go.drugbank.com/drugs/DB05710
    Investigational

    It is being developed by Avera Pharmaceuticals.

  6. Drug

    Orbifloxacin

    go.drugbank.com/drugs/DB11443
    ExperimentalVet approved

    It is marketed by Schering-Plough Animal Health and approved for certain infections in dogs.

  7. Drug

    Royal jelly

    go.drugbank.com/drugs/DB14250
    Investigational

    It is not an approved drug.

  8. Drug

    Rosemary

    go.drugbank.com/drugs/DB14272
    Investigational

    It is not an approved drug.

  9. Drug

    AT-GTX-502

    go.drugbank.com/drugs/DB17001
    Experimental

    AT-GTX-502 is an experimental, one-time gene therapy that uses AAV9 to deliver a functional copy of CLN3.

  10. Drug

    Encenicline

    go.drugbank.com/drugs/DB11726
    Investigational

    Encenicline has been investigated for the treatment of Cognition, Schizophrenia, Alzheimer's Disease, Cardiac Repolarization, and Central Nervous System Diseases.